Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy POSEIDON-DCM Trial

Overview of attention for article published in JACC, November 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

news: 4 news outlets
twitter: 28 X users
patent: 1 patent

facebook: 3 Facebook pages
f1000: 1 research highlight platform
guideline: 1 clinical guideline source

Readers on

mendeley: 294 Mendeley

So far, Altmetric has seen 6 public wall posts from 3 users.

American College of Cardiology - New Jersey Chapter, 02 Mar 2018

Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy

American College of Cardiology - New Jersey Chapter, 17 Jan 2018

Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy http://www.on…

Asociación Colombiana de Medicina Interna, 02 Feb 2017

Allogeneic vs. autologous stem cells in nonischemic CM: Can they improve EF? See the results here #JACC http://ow.ly/Ch5p308CtNj…

Asociación Colombiana de Medicina Interna, 02 Feb 2017

Stem cells in nonischemic CM: Do they work? #JACC http://ow.ly/KnyT308CtFs pic.twitter.com/EEkjg8wLbv

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity, including 2 additional Facebook posts.